Camber Capital Management

Camber Capital Management as of Sept. 30, 2014

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 35 positions in its portfolio as reported in the September 2014 quarterly 13F filing

Company (Ticker)
Portfolio Weight
Valued At
Change in Shares
Share Count
Share Price
Teva Pharmaceutical Industries (TEVA) 11.4 $121M 2.3M 53.75
GlaxoSmithKline 9.5 $101M 2.2M 45.97
Mylan 6.0 $64M 1.4M 45.49
Masimo Corporation (MASI) 5.4 $58M 2.7M 21.28
Genomic Health 5.3 $57M 2.0M 28.31
Volcano Corporation 5.0 $54M 5.1M 10.64
CONMED Corporation (CNMD) 4.8 $51M 1.4M 36.84
Express Scripts Holding 4.7 $49M 700k 70.63
Keryx Biopharmaceuticals 4.5 $48M 3.5M 13.75
Vertex Pharmaceuticals Incorporated (VRTX) 4.2 $45M 400k 112.31
Orthofix International Nv Com Stk 3.5 $38M 1.2M 30.96
Universal American 3.2 $34M 4.2M 8.04
Achillion Pharmaceuticals 3.0 $32M 3.3M 9.98
Ariad Pharmaceuticals 3.0 $32M 6.0M 5.40
Quest Diagnostics Incorporated (DGX) 2.9 $30M 500k 60.68
Weight Watchers International 2.6 $27M 1.0M 27.44
AMAG Pharmaceuticals 2.2 $24M 750k 31.91
Sequenom 2.2 $24M 8.0M 2.97
Novavax 1.9 $20M 4.8M 4.17
Bruker Corporation (BRKR) 1.7 $19M 1.0M 18.52
ICU Medical, Incorporated (ICUI) 1.7 $18M 278k 64.18
Bio-Reference Laboratories 1.4 $15M 544k 28.06
WellCare Health Plans 1.3 $14M 235k 60.34
Otonomy 1.3 $14M 573k 24.00
Amarin Corporation (AMRN) 1.2 $13M 12M 1.09
Cross Country Healthcare (CCRN) 0.9 $9.3M 1.0M 9.29
Cardica 0.8 $9.0M 8.4M 1.07
GenMark Diagnostics 0.8 $8.1M 908k 8.97
Geron Corporation (GERN) 0.7 $6.9M 3.4M 2.00
Ptc Therapeutics I (PTCT) 0.7 $7.0M 158k 44.01
Biolase Technology 0.6 $6.8M 2.7M 2.49
AngioDynamics (ANGO) 0.5 $5.0M 365k 13.72
Protalix BioTherapeutics 0.5 $4.8M 2.0M 2.42
Targacept 0.4 $3.9M 1.6M 2.53
Inovio Pharmaceuticals 0.2 $2.5M 250k 9.85